Daily news

Using evidence as the guiding star, the @ducrest Twitter timeline consists of the latest scientific publications in dermatology, cosmetic dermatology, cosmetics and Home-Use devices. Here you will find interesting information gleaned from science and technology sources as well as the lay press.

« page 2033

BoNTA-INC RC 2xblind phase3 trial for glabellar frown lines using a stringent composite endpoint ncbi.nlm.nih.gov/pubmed/23506308 #Merz #Bocouture

2:28am Sep 6 2013 —

Phase IV study: BoNTA-INC vs BoNTA-ONA using a 1:1.5 dose-conversion ratio for glabellar frown lines ncbi.nlm.nih.gov/pubmed/23174049 #Merz #Allergan

2:24am Sep 6 2013 —

South American Glabellar Experience Study (SAGE) – BoNTA-INC Multicenter Retrospective Analysis in Argentina ncbi.nlm.nih.gov/pubmed/23990584 #Merz

2:22am Sep 6 2013 —

PDT with ablative carbon dioxide fractional laser for treating Bowen disease ncbi.nlm.nih.gov/pubmed/24003277 #lasers #dermatology

2:15am Sep 6 2013 —

Laser-guided surgery finds brain cancer’s boundary. Potential insights into #NMskincancer boundaries zite.to/1ehIE94

5:44am Sep 5 2013 —

When will genetic infos drive #cosmeticdermatology & #dermatology? Research into ‘personalised’ medicine! zite.to/18v7OMG

5:40am Sep 5 2013 —

Refining injection techniques dermatologytimes.modernmedicine.com/dermatology-ti… @DermTimesNow #cosmeticdermatology

4:06am Sep 5 2013 —

Calcium Hydroxylapatite: safety & tolerability overview jddonline.com/articles/derma… #dermalfillers Journal of Drugs in Dermatology @SculptraAest

3:59am Sep 5 2013 —

Face, Hand, and Decolletage: with Stabilized HA of Non-animal Origin for Skin Rejuvenation jddonline.com/articles/derma… #dermalfiller

3:55am Sep 5 2013 —

Pain management: Topical Lidocaine & Tetracaine 7%/7% Cream with Laser Dermatologic Procedures jddonline.com/articles/derma… #lasers #dermatology

3:53am Sep 5 2013 —